|
Market Closed -
Euronext Paris
11:55:00 2026-10-09 am EDT
|
5-day change | 1st Jan Change | ||
| 2.230 EUR | +0.45% |
|
+1.36% | -17.71% |
| Oct. 01 | Taconic Biosciences, Inc. And genOway Partner To Expand U.S. Access To Advanced Humanized Mouse Models | CI |
| Sep. 23 | GenOway teams up with Taconic Biosciences to accelerate in the United States |  |
| Market Cap | 20.56M 23.02M 19.13M 17.4M 32.85M 2.23B 32.99M 230M 90.2M 1.14B 86.45M 84.56M 3.65B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 27.28M 30.54M 25.38M 23.08M 43.58M 2.96B 43.77M 305M 120M 1.51B 115M 112M 4.84B | EV / Sales 2024 |
1.36x | EV / Sales 2025 | 1.22x |
| Free-Float |
59.02% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALGEN | Real-time | |
Boerse Muenchen
| JEH | Real-time | |
|
Deutsche Boerse AG
| JEH | Delayed | |
|
Börse Stuttgart
| JEH | Delayed |
| 1 day | +0.45% | ||
| 1 week | +1.36% | ||
| Current month | -4.70% | ||
| 1 month | -10.80% | ||
| 3 months | -7.08% | ||
| 6 months | -8.61% | ||
| Current year | -17.71% |
| 1 week | 2.01 |  | 2.42 |
| 1 month | 2.01 | | 2.5 |
| Current year | 2.01 | | 2.79 |
| 1 year | 2.01 | | 2.98 |
| 3 years | 2.01 | | 4.91 |
| 5 years | 2.01 | | 4.91 |
| 10 years | 1 | | 7.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Operating Officer | - | 1999-02-28 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 2015-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 1999-02-28 | |
| Chairman | - | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/20/22 | Buy | Chief Executive Officer | 12,500 | 0.1376% | ||
| 11/17/21 | Sell | Chief Executive Officer | 5,000 | 0.0553% | ||
| 11/13/21 | Sell | Founder | 1,147 | 0.0127% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.45% | +1.36% | -24.41% | -46.52% | 23.02M | |
| -2.59% | -5.70% | +50.69% | +86.86% | 70.61B | |
| +3.23% | -10.67% | +6.27% | +53.70% | 51.01B | |
| +1.56% | +1.17% | +8.49% | +31.81% | 48.1B | |
| +0.39% | +0.65% | +31.14% | +28.97% | 42.78B | |
| +0.87% | -8.17% | +293.37% | +642.41% | 40.67B | |
| +1.24% | -1.01% | +10.74% | +100.64% | 40.3B | |
| -2.13% | -1.64% | +8.63% | +46.88% | 30.59B | |
| -0.46% | -1.28% | +42.23% | +20.34% | 28.16B | |
| +5.32% | +0.06% | -5.00% | -12.78% | 24.36B | |
| Average | +0.79% | -2.25% | +42.22% | +95.23% | 37.66B | |
| Weighted average by Cap. | +0.56% | -2.94% | +51.34% | +115.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 25.84M 28.94M 24.04M 21.87M 41.29M 2.8B 41.47M 289M 113M 1.43B 109M 106M 4.58B | 26.03M 29.15M 24.21M 22.03M 41.59M 2.82B 41.77M 291M 114M 1.44B 109M 107M 4.61B |
| Net income | 1.83M 2.05M 1.7M 1.55M 2.92M 198M 2.94M 20.5M 8.03M 101M 7.7M 7.53M 325M | 928K 1.04M 863K 785K 1.48M 101M 1.49M 10.39M 4.07M 51.26M 3.9M 3.82M 164M |
| Net Debt | 623K 698K 580K 527K 995K 67.51M 1M 6.97M 2.73M 34.42M 2.62M 2.56M 110M | 6.72M 7.52M 6.25M 5.68M 10.73M 728M 10.78M 75.22M 29.47M 371M 28.25M 27.63M 1.19B |
Employees
163
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-09 | €2.230 | +0.45% | 20,795 |
| 26-10-08 | €2.220 | -7.50% | 20,095 |
| 26-10-07 | €2.400 | 0.00% | 23,004 |
| 26-10-06 | €2.400 | +5.26% | 11,147 |
| 26-10-05 | €2.280 | +3.64% | 33,797 |
- Stock Market
- Stocks
- ALGEN Stock
Select your edition
All financial news and data tailored to specific country editions
